文献速递分子诊断临床微生物

基于全基因组测序直接从阳性血培养样本中表征链球菌病原体

Whole-genome sequencing-based pathogen characterization for streptococcal infection directly from positive blood culture samples.
PubMed 文献 · J Clin Microbiol · 2025-12-08

该研究评估直接从阳性血培养样本进行全基因组测序(dWGS)以表征链球菌病原体的方法。97份合格样本中83份(86%)通过质控,共655项检测获651项(99.3%)可评估结果。与参考方法相比,emm/荚膜分型、MLST分型和基因型药敏预测的符合率均为100%,假 resistant 和假 susceptible 预测率均为0%。

要点

  • dWGS可直接从阳性血培养样本获得高质量链球菌菌株特征,无需提交临床分离株。
  • 与参考方法相比,dWGS在emm/荚膜分型、MLST分型和基因型药敏预测上符合率均为100%。
  • 同一患者病原体基因组组装平均差异为1.08±1.68 sites/genome。

核心结论

  • dWGS可直接从阳性血培养样本提取高质量链球菌菌株特征,支持公共卫生监测和暴发应对。

研究设计与样本

  • 研究纳入97份ABCs链球菌病原体阳性血培养样本,采用dWGS检测并与同一培养物分离株的参考WGS比较。

主要发现

  • 83份(86%)样本通过dWGS质控,655项检测中651项(99.3%)可评估。
  • emm/荚膜分型与参考结果符合率为100%(83/83),MLST分型符合率为100%(81/81)。
  • 基因型药敏预测符合率为100%(487/487),假 resistant 预测率为0%(0/417),假 susceptible 预测率为0%(0/66)。
  • 同一患者病原体基因组组装差异为1.08±1.68(mean±SD)sites per genome。

临床怎么用

  • 临床实验室可直接对阳性血培养样本进行dWGS,无需先分离菌株即可获得疫苗血清型和基因组相关性等信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Clinical laboratories are increasingly using diagnostic tests directly on positive blood cultures, which may lead to fewer attempts to recover bacterial isolates. Consequently, public health laboratories can benefit from assays that directly process blood culture samples without requiring submission of clinical isolates to determine additional pathogen features not identified by clinical tests, such as vaccine serotype and bacterial genomic relatedness, for surveillance and outbreak response purposes. In partnership with the Minnesota Active Bacterial Core surveillance (ABCs) site, we identified blood culture samples positive for ABCs streptococcal pathogens and characterized them by a direct whole-genome sequencing from blood culture (dWGS) assay. The dWGS results were compared with the results of a reference method (WGS of isolates from the same cultures) to evaluate concordance in pathogen features and genome assemblies. Of the 97 eligible blood culture samples, 83 (86%) passed dWGS quality control criteria and were subjected to a total of 655 dWGS-based tests, which yielded 651 (99.3%) evaluable results. The percent agreement with reference results was 100% (83/83) for M protein gene (emm)/capsular types and 100% (81/81) for multilocus sequencing types. For genotypic antimicrobial susceptibility testing prediction, the percent prediction agreement was 100% (487/487), false resistant prediction rate was 0% (0/417), and the false susceptible prediction rate was 0% (0/66). Assemblies of pathogen genomes from the same patient differed by 1.08 ± 1.68 (mean ± SD) sites per genome. The dWGS assay can extract high-quality, important streptococcal strain characteristics directly from positive blood culture samples to support evolving public health needs.IMPORTANCEWhole-genome sequencing (WGS) technologies have emerged as a transformative toolkit used by public health microbiology laboratories to detect and characterize pathogens. The surveillance of bacterial diseases often relies on clinical laboratories to submit pathogen isolates to regional or national public health laboratories, which have the capacity to routinely conduct WGS-based strain characterization. Clinical laboratories are increasingly using diagnostic tests directly on positive blood cultures, which may lead to fewer attempts to recover bacterial isolates. The study evaluated a direct whole-genome sequencing from blood culture (dWGS) assay that directly processes blood culture samples. The dWGS assay recovered high quality, important streptococcal strain characteristics, including vaccine serotypes and whole-genome assemblies, without requiring submission of clinical isolates. Thus, the dWGS assay represents a promising tool for addressing the evolving needs of public health laboratories in the metagenomics era.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Li Y, Lin W, Li Z, et al. Whole-genome sequencing-based pathogen characterization for streptococcal infection directly from positive blood culture samples. J Clin Microbiol. 2025. PMID: 41358744. doi:10.1128/jcm.01126-25

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。